The U.S. Treasury Department said on Thursday that New York-based insurer MetLife's unit, American Life Insurance Company, ...
Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, ...
Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
The University of Pittsburgh is studying ways to improve the lives of Type 2 diabetics, or people who just want to control ...
"Full House" actor Dave Coulier, 65, revealed he has stage 3 non-Hodgkin's lymphoma. ( People) The latest tally of the ...
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
Insulet’s Omnipod 5 automated insulin delivery (AID) system has multiple avenues to expand as it has revolutionized the way patients treat their diabetes, including the new indication for Type 2 ...
From wearable glucose monitors to AI-driven health insights, recent advances are giving patients new ways to manage blood ...
The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.
Traditionally, scientists believed that obesity led to type 2 diabetes by impairing insulin signaling within liver and fat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback